Er-xian decoction

Er-xian decoction has been studied in 3 papers since 2022: 1 trial in people, 1 in animals, 1 review; 1 in the past year. The newest paper, May 14, 2026: “Er-xian Decoction: A comprehensive review on chemical constituents, quality control, pharmacokinetics, pharmacological properties and clinical applications”.

Intervention

3 papers study it3 findingsUpdated

MeSH

See all 3 papers on er-xian decoction

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“serum anti-Mullerian hormone (AMH) level in DOR patients with EXD treatment was higher than that in DOR patients without EXD treatment”
Kaempferol exerts antioxidant effects in age-related diminished ovarian reserve by regulating the HSP90/NRF2 pathwayChemical biology & drug design2023doi:10.1111/cbdd.14385
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Human trial1
  • Animals1

What did studies of er-xian decoction find?

3

Studies of er-xian decoction measured 3 outcomes: osteoporosis, menopausal syndrome and anti-Müllerian hormone.

Osteoporosis

downin humans1

1 study
  1. Er-xian decoction decreases osteoporosis in osteoporosis.

    “improve symptoms in patients with menopausal syndrome, osteoporosis, and premature ovarian failure, based on randomized trials involving thousands of patients”

    Reviewin osteoporosis

    Er-xian Decoction: A comprehensive review on chemical constituents, quality control, pharmacokinetics, pharmacological properties and clinical applications

    Phytomedicine : international journal of phytotherapy and phytopharmacology

More on Osteoporosis

Menopausal syndrome

downin humans1

1 study
  1. Er-xian decoction decreases menopausal syndrome in menopausal syndrome.

    “improve symptoms in patients with menopausal syndrome, osteoporosis, and premature ovarian failure, based on randomized trials involving thousands of patients”

    Reviewin menopausal syndrome

    Er-xian Decoction: A comprehensive review on chemical constituents, quality control, pharmacokinetics, pharmacological properties and clinical applications

    Phytomedicine : international journal of phytotherapy and phytopharmacology

More on Menopausal syndrome

Anti-Müllerian hormone

upin humans1

1 study
  1. Er-xian decoction increases anti-Müllerian hormone in DOR patients.

    “serum anti-Mullerian hormone (AMH) level in DOR patients with EXD treatment was higher than that in DOR patients without EXD treatment”

    Human trialin DOR patients

    Kaempferol exerts antioxidant effects in age-related diminished ovarian reserve by regulating the HSP90/NRF2 pathway

    Chemical biology & drug design

More on Anti-Müllerian hormone

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months